Grapefruit USA (OTCQB: GPFT), a fully licensed manufacturer and distributor in the legal cannabis marketplace, has created a revolutionary product: The Hourglass(TM) THC+ Cannabinoid delivery cream. The cream solves two problems, the first being that cannabis lovers no longer need to ingest cannabinoids to enjoy them. “For the first time, cannabis enthusiasts can enjoy a full, discrete, convenient cannabis experience without rolling, smoking or vaping,” reads a recent article. Secondly, “Grapefruit’s disruptive cream solves the previous problem of THC and other cannabinoids not being easily absorbable through the skin. Using Grapefruit’s proprietary delivery system, Hourglass topical cream creates a Patchless Patch(TM) on the top of the skin. The system features patented microsized particles that effectively deliver THC and a wide range of cannabinoids through topical administration.”
To view the full article, visit https://cnw.fm/KdtwZ
About Grapefruit USA Inc.
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’s Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.
NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.
